Prenatal antibiotic use and subsequent risk of atopic eczema
Br J Dermatol
.
2023 Mar 30;188(4):561-563.
doi: 10.1093/bjd/ljac108.
Authors
Terrence M Vance
1
2
,
Tricia Li
1
,
Eunyoung Cho
1
2
3
,
Aaron M Drucker
1
4
5
,
Carlos A Camargo
3
6
7
,
Abrar A Qureshi
1
2
3
Affiliations
1
Department of Dermatology, Warren Alpert Medical School of Brown University.
2
Department of Epidemiology, School of Public Health, Brown University, Providence, RI, USA.
3
Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School.
4
Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Canada.
5
Women's College Research Institute and Department of Medicine, Women's College Hospital, Toronto, Canada.
6
Department of Emergency Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
7
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
PMID:
36689333
DOI:
10.1093/bjd/ljac108
No abstract available
MeSH terms
Anti-Bacterial Agents / adverse effects
Dermatitis, Atopic* / drug therapy
Eczema* / drug therapy
Eczema* / etiology
Female
Humans
Pregnancy
Risk Factors
Vitamins
Substances
Anti-Bacterial Agents
Vitamins
Grants and funding
U01HL145386/Growing Up Today Study
NH/NIH HHS/United States
NH/NIH HHS/United States